
Zumutor Biologics
Zumutor Biologics is an Indian biotechnology company developing antibody-based cancer immunotherapies. Its lead candidate targets the LAIR1 immune checkpoint pathway, and the company has pursued United States clinical development for its oncology programmes.
Funding
Jun 2026Pre-Series B$7.3MAccel, Bharat Innovation Fund, Premji Invest, Ashish Kacholia, Raj Dandu Family Office